Literature DB >> 26670267

Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe.

Olga Löblová1.   

Abstract

In the past two decades, setting up independent health technology assessment (HTA) agencies has become a popular tool to inform reimbursement decision-making in health care, spreading from Northern European countries across Western Europe but much less so to post-communist countries. Structural political science explanations leave gaps in clarifying this diffusion pattern. This paper proposes a theoretical model focusing on the influence of domestic epistemic communities mitigating policy diffusion. Based on a review of HTA institutions in the EU, it proposes a chronological taxonomy of HTA agencies in Europe (the forerunners, the mainstreamers and the non-adopters) and asks why there is such an important East-West divide. The paper discusses theoretical explanations from different literatures, finding unsatisfactory many traditional political science answers such as the degree of centralization of a country's health system, its financial organization (Bismarckian or Beveridgian), the attitude toward independent regulatory bodies in general, the influence of international actors, or lack of resources. Finally, it suggests cases for empirical testing of the domestic epistemic communities model.

Entities:  

Mesh:

Year:  2015        PMID: 26670267     DOI: 10.1017/S1744133115000444

Source DB:  PubMed          Journal:  Health Econ Policy Law        ISSN: 1744-1331


  3 in total

1.  Evidence-based decision-making for diagnostic and therapeutic methods: the changing landscape of assessment approaches in Germany.

Authors:  Britta Olberg; Sabine Fuchs; Katja Matthias; Alexandra Nolting; Matthias Perleth; Reinhard Busse
Journal:  Health Res Policy Syst       Date:  2017-10-17

Review 2.  Health technology assessment of biosimilars worldwide: a scoping review.

Authors:  Bruna de Oliveira Ascef; Ana Carolina de Freitas Lopes; Patrícia Coelho de Soárez
Journal:  Health Res Policy Syst       Date:  2020-08-26

3.  Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer.

Authors:  Beata Kiselova Bilekova; Beata Gavurova; Vladimír Rogalewicz
Journal:  Health Econ Rev       Date:  2018-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.